Clinical Trial Update: Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor [Phase 3]

View source ↗

Summary

Phase 3 trial investigating idalopirdine in mild-to-moderate Alzheimer's disease patients already on acetylcholinesterase inhibitors; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Idalopirdine (idalopirdine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-02-07